Xianglai Xu
- Topics
- Renal cell carcinoma treatment (14 papers)MicroRNA in disease regulation (13 papers)Circular RNAs in diseases (10 papers)
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Xianglai Xu
42 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 838
- Cancer Research 675
- Pulmonary and Respiratory Medicine 194
- Surgery 160
- Oncology 139
Countries citing papers authored by Xianglai Xu
This map shows the geographic impact of Xianglai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglai Xu more than expected).
Fields of papers citing papers by Xianglai Xu
This network shows the impact of papers produced by Xianglai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglai Xu. The network helps show where Xianglai Xu may publish in the future.
Co-authorship network of co-authors of Xianglai Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Xianglai Xu. A scholar is included among the top collaborators of Xianglai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianglai Xu. Xianglai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 5 | |
| 6 | 9 | |
| 7 | 14 | |
| 8 | 2 | |
| 9 | 62 | |
| 10 | 58 | |
| 11 | 50 | |
| 12 | 99 | |
| 13 | 21 | |
| 14 | 41 | |
| 15 | 58 | |
| 16 | 50 | |
| 17 | 95 | |
| 18 | 77 | |
| 19 | 51 | |
| 20 | 10 |
About Xianglai Xu
Xianglai Xu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Hepatology, having authored 44 papers that have together received 1.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (14 papers), MicroRNA in disease regulation (13 papers) and Circular RNAs in diseases (10 papers). The work is most often cited by research in Cancer Research (675 citations), Molecular Biology (838 citations) and Biochemistry (51 citations). Xianglai Xu has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Liping Xie, Zhenghui Hu, Jian Wu, Xiangyi Zheng, Xin Xu, Yeqing Mao, Yiwei Lin, Shiqi Li, Yi Zhu and Liping Xie. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.